Subjects: Biomarkers / Titles: Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Biomarkers ✖ Titles Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment ✖

1. Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment